IRulya Therapeutics Inc. Common Stock (IRLA) Stock Price

IRLAStock
$32.03
Market Cap$32.58M
P/E—
PEG Ratio—
Div yield—
Beta—

IRLA Share Price Chart

Favorite Metrics

VGM Score71.84

IRLA Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$12.39-$12.15+1.88%(+$0.23)
Q1 2026-$52.00$57.60+210.77%(+$109.60)
Q4 2025-$45.00-$152.00-237.78%(-$107.00)
Q3 2025-$44.50-$50.00-12.36%(-$5.50)

Industry Peers — Biological Products(186)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)EPS Growth (5Y)Price
IRLAIRulya Therapeutics Inc. Common Stock
——B————$32.03
AMGNAmgen IncDCA6.1x9.1%74.3%2.9%$432.49
GILDGilead Sciences IncCBA6.4x5.5%79.6%133.6%$156.19
MRNAModerna, Inc. Common StockFCA39.1x-27.6%36.4%—$218.01
ARGXargenx SE American Depositary SharesDAB6.6x165.2%89.8%—$819.14
RVMDRevolution Medicines, Inc. Common StockF—B3296.2x———$177.96
BIIBBiogen Inc. Common StockCDA3.4x0.3%74.0%-18.8%$232.65
BNTXBioNTech SE American Depositary ShareCCC7.6x-11.8%79.2%—$87.71
EXELExelixis IncCBA6.3x9.2%96.5%31.1%$62.23
HALOHalozyme Therapeutics, Inc.DBA8.3x41.1%82.4%22.9%$121.84
NBIXNeurocrine Biosciences IncCBB4.1x34.4%98.0%2.3%$135.71